Description
A bioactive sphingolipid; synthetic stereoisomer of sphingosine; inhibits PKC in vitro (IC50 = 3.3 mol%); inhibits PMA-induced superoxide generation in neutrophils and reduces growth of CHO cells (IC50s = 1.3 and 2 μM, respectively); inhibits dephosphorylation of pRB (EC50 = 5 μM) and growth of MOLT-4 cells (IC50 = 3.7 μM)
Formal name: (2R,3S,4E)-2-amino-4-octadecene-1,3-diol
Synonyms: L-erythro Sphingosine|L-erythro-C18-Sphingosine
Molecular weight: 299.5
CAS: 6036-75-5
Purity: ≥98%
Formulation: A solid
Product Type|Biochemicals|Kinase Inhibitors|PKC||Product Type|Biochemicals|Lipids|Sphingolipids||Product Type|Biochemicals|Ox Stress Reagents|Antioxidants||Product Type|Biochemicals|Small Molecule Inhibitors|Kinases||Research Area|Cancer|Cell Signaling|PKC Signaling||Research Area|Immunology & Inflammation|Innate Immunity||Research Area|Lipid Biochemistry|Sphingolipids